In this guide
What is MCT Oil?
MCT oil is a mixture of medium-chain triglycerides, often C8 and C10. Ketone production, tolerability and trial outcomes depend on the formulation and actual amount consumed. No U.S. DRI or routine therapeutic intake is established for MCT oil. It is an energy-containing fat, not an essential-fatty-acid requirement.
Typical MCT Oil Protocols
| Source and population | Form and amount each time | Frequency | Total exposure | Duration or boundary |
|---|---|---|---|---|
| Juby 2022 · probable Alzheimer disease | MCT oil titrated from 15 mL per administration | Week 1 once daily; week 2 twice daily; week 3 up to three times daily | Target 42 g/day or maximum tolerated; mean tolerated 25.2 g/day | 6-month crossover plus open-label extension |
| McKenzie 2021 · blood-lipid synthesis | MCT oils replaced other dietary fats | Study-specific | No single pooled regimen | 7 randomized articles of at least 2 weeks |
| Product audit | C8/C10 composition and measured grams | Each administration | Calculate total fat and calories | Increase only within a clinician/dietitian plan |
These rows reproduce sources. Do not average them into one universal regimen.
From source to outcome
Not the same as coconut oil.
Mean tolerated 25.2 g/day.
Comparator-dependent average.
Which forms and label details matter?
Record grams and millilitres separately, plus C8, C10 and other fatty-acid composition. Coconut oil is not equivalent to a purified C8/C10 product. A tablespoon volume cannot be converted to grams without the product’s density or label.
How should it be stored?
Follow the label, close the container and protect it from heat, light and moisture.
Read the label before the claim
Match the studied preparation.
Keep the daily total visible.
A biomarker is not a clinical event.
What is it commonly used for?
MCT oil is used to raise ketones, support cognition, assist ketogenic diets and promote weight loss. Evidence is mixed, short and often compares MCT with a long-chain fat rather than no calories.
What does human research show?
Juby’s single-centre Alzheimer study used a one-month titration from 15 mL once daily toward three administrations and a 42 g/day target or maximum tolerated dose; the mean tolerated intake was 25.2 g/day. The small crossover and open-label study suggested some cognitive signals, but it cannot establish prevention, disease modification or a retail self-treatment regimen. [1] McKenzie pooled seven randomized articles lasting at least two weeks. Compared with control fats, MCT did not clearly change total, LDL or HDL cholesterol but raised triglycerides by about 0.14 mmol/L overall; effects differed by comparator. [2] Earlier weight syntheses report small average differences when MCT replaces long-chain fat, while a 2024 synthesis remains heterogeneous. [3] Added calories, GI tolerance and comparator choice matter.

How might it act?
Fatty acids enter membranes, serve as energy substrates or act as precursors to mediators according to their structure. This mechanism does not turn a blood-level change into prevention of a clinical event.
How does it compare with related products?
| Product | Label identity | Practical distinction |
|---|---|---|
| MCT oil | Grams, millilitres, C8 and C10 | Rapidly absorbed triglycerides; still supplies energy and can cause GI symptoms. |
| Fish oil | EPA, DHA and total oil | Long-chain omega-3 evidence does not transfer to MCT oil. |
| Flaxseed oil | ALA and total oil | Essential omega-3 precursor, not a C8/C10 concentrate. |
What are the risks and interactions?
Large or rapid administrations commonly cause cramping, nausea or diarrhea and can undermine adherence. Review diabetes medicines, ketogenic therapy, liver disease, pancreatic or fat-malabsorption disorders, pregnancy and breastfeeding. MCT oil is calorie-dense and should not displace essential fats.
Which medicines require review?
Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.
Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [4], [5]
What should be monitored?
Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.
What happens when it is stopped?
No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.
Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.
What do public communities report?
Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.
Common questions about MCT Oil
Is MCT oil the same as coconut oil?
No. Coconut oil contains a broader fatty-acid profile and much less concentrated C8/C10.
Does it treat Alzheimer disease?
No established treatment claim follows from one small crossover/open-label study.
Why titrate it?
GI intolerance is common; the exact clinical trial schedule should not be converted into a universal plan.
Does it cause weight loss?
Average effects are small and depend on replacing another fat, not simply adding calories.
Does it improve cholesterol?
The current synthesis found no clear total, LDL or HDL benefit and a modest triglyceride increase.
What should I track?
C8/C10, grams and mL, each administration, meals, GI symptoms, calories, lipids and review date.
Glossary
Terms for reading the evidence.
- ALA
- Essential 18-carbon omega-3; adult AIs refer to this form.
- EPA
- Long-chain omega-3; distinct from total oil weight.
- DHA
- Long-chain omega-3; often present in a different amount from EPA.
- Amount per administration
- Amount consumed at one time, distinct from daily total.
- Biomarqueur
- Biological measure that is not necessarily a clinical benefit.
- UL
- Tolerable Upper Intake Level established for a nutrient and defined scope.
How this guide was researched
Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.
Explore the sources
Sources preserve form, amount, frequency, population, duration and outcome.
Showing 5 sources
- 01
Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double-blind, placebo-controlled, crossover study, with an open-label extension. ↗
Randomized crossover trial with extension
Current page or report reviewed; scope and limits retained.
Detail: Probable Alzheimer disease; exact titration, target and tolerated dose.
- 02
Medium-Chain Triglyceride Oil and Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Trials. ↗
Systematic review and meta-analysis
Current page or report reviewed; scope and limits retained.
Detail: Seven randomized articles; lipid findings depend on comparator fat.
- 03
The impact of medium-chain triglycerides on weight loss and metabolic health ↗
Systematic review and meta-analysis
Current page or report reviewed; scope and limits retained.
Detail: Current synthesis of weight and metabolic outcomes in overweight or obesity.
- 04
Questions and Answers on Dietary Supplements ↗
U.S. regulatory overview
Current page or report reviewed; scope and limits retained.
Detail: Supplements generally lack efficacy preapproval.
- 05
Product Licensing ↗
Canadian licensing overview
Current page or report reviewed; scope and limits retained.
Detail: Finished natural health products require licensing and authorized labels.
No matching sources
Try a different term or show the full list.